Literature DB >> 17047121

Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

B Iacopetta, T Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17047121      PMCID： PMC1860101     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

1.  P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

Authors:  H Elsaleh; B Powell; K McCaul; F Grieu; R Grant; D Joseph; B Iacopetta
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  BRAF mutation and gene methylation frequencies of colorectal tumours with microsatellite instability increase markedly with patient age.

Authors:  B Iacopetta; W Q Li; F Grieu; A Ruszkiewicz; K Kawakami
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Microsatellite instability and colorectal cancer prognosis.

Authors:  Piero Benatti; Roberta Gafà; Daniela Barana; Massimiliano Marino; Alessandra Scarselli; Monica Pedroni; Iva Maestri; Laura Guerzoni; Luca Roncucci; Mirco Menigatti; Barbara Roncari; Stefania Maffei; Giuseppina Rossi; Giovanni Ponti; Alessandra Santini; Lorena Losi; Carmela Di Gregorio; Cristina Oliani; Maurizio Ponz de Leon; Giovanni Lanza
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

4.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

5.  Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified.

Authors:  Robyn Lynne Ward; Jenny Turner; Rachel Williams; Brita Pekarsky; Deborah Packham; Marija Velickovic; Alan Meagher; Terence O'Connor; Nicholas John Hawkins
Journal:  J Pathol       Date:  2005-12       Impact factor: 7.996

6.  Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.

Authors:  A Hemminki; J P Mecklin; H Järvinen; L A Aaltonen; H Joensuu
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

7.  High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection.

Authors:  Jin-Tung Liang; Kuo-Chin Huang; Hong-Shiee Lai; Po-Huang Lee; Yung-Ming Cheng; Hey-Chi Hsu; Ann-Lii Cheng; Chih-Hung Hsu; Kun-Huei Yeh; Shih-Ming Wang; Chi Tang; King-Jen Chang
Journal:  Int J Cancer       Date:  2002-10-20       Impact factor: 7.396

8.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

9.  Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.

Authors:  W M Brueckl; C Moesch; T Brabletz; C Koebnick; C Riedel; A Jung; S Merkel; S Schaber; F Boxberger; T Kirchner; W Hohenberger; E G Hahn; A Wein
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

Review 10.  Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.

Authors:  Henry T Lynch; C Richard Boland; Gordon Gong; Trudy G Shaw; Patrick M Lynch; Riccardo Fodde; Jane F Lynch; Albert de la Chapelle
Journal:  Eur J Hum Genet       Date:  2006-04       Impact factor: 4.246
View more
  2 in total

Review 1.  Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?

Authors:  Barry Iacopetta; Kazuyuki Kawakami; Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 2.  Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.

Authors:  Inés Mármol; Cristina Sánchez-de-Diego; Alberto Pradilla Dieste; Elena Cerrada; María Jesús Rodriguez Yoldi
Journal:  Int J Mol Sci       Date:  2017-01-19       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.